Terminated NA INTERVENTIONAL 3-arm NCT05415293

Commerical DHA Supplementation

Serum Docosahexaenoic Acid After Third Trimester Commercially Available Supplementation: a Randomized Clinical Trial

Sponsor: National Center for Research Resources (NCRR)

Conditions Docosahexaenoic Acid Pregnancy Randomized Clinical Trial

Interventions Expecta 200mg DHA Promise 275mg DHA

Updated 4 times since 2022 Last updated: Jan 9, 2024 Started: May 31, 2011 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI has confirmed there are no results because the samples were degraded.

Other terminated trials from National Center for Research Resources (NCRR)

See all terminations from National Center for Research Resources (NCRR)

Listed as NCT05415293, this NA trial focuses on Docosahexaenoic Acid and Pregnancy and remains terminated or withdrawn. Sponsored by National Center for Research Resources (NCRR), it has been updated 4 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Feb 2024 — Jul 2024 [monthly]

Terminated NA

Status: Completed → Terminated
Jul 2022 — Feb 2024 [monthly]

Completed NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
University of New Mexico

Data source: University of New Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Albuquerque, United States